This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: The Innovative Mind of Kimberly Walter
Introduction: Kimberly Walter, based in South San Francisco, CA, is a remarkable inventor whose contributions to the field of cancer research are noteworthy. As a dedicated professional at Genentech, Inc., she has focused her efforts on developing new methods for cancer treatment, earning recognition for her innovative work.
Latest Patents: Walter holds a patent for "PD-L1 promoter methylation in cancer." This invention provides groundbreaking methods for treating cancer in subjects exhibiting medium or low methylation levels in the PD-L1 promoter region. Additionally, the patent encompasses related kits and articles of manufacture, showcasing her commitment to advancing medical treatments.
Career Highlights: Kimberly Walter's career is marked by her role at Genentech, Inc., where her research has significantly impacted the approach to cancer therapies. Her determination and expertise have positioned her as a valuable asset in the field, reflecting her passion for improving patient outcomes.
Collaborations: Throughout her career, Walter has collaborated with esteemed colleagues such as Edward Kadel and Marcin Kowanetz. These partnerships illustrate the importance of teamwork in driving innovation and advancing research in the complex world of cancer treatment.
Conclusion: Kimberly Walter's dedication to her work and her innovative contributions have made a lasting impact on cancer research. With her patent on PD-L1 promoter methylation, she continues to pave the way for new therapeutic approaches, demonstrating the crucial role of inventors in the advancement of healthcare solutions.